Skip to main content
. 2017 Apr 29;2(3):281–287. doi: 10.1016/j.adro.2017.04.007

Table 1.

Patient characteristics

Characteristic n (%)
Age
 ≥65 y 17 (15.4)
 <65 y 93 (84.6)
Gender
 Female 62 (56.4)
 Male 48 (43.6)
HIV Infection Status
 + 31 (28.2)
 − 79 (71.8)
Tumor Stage
 1-2 64 (58.2)
 3-4 46 (41.8)
Node Stage
 0 65 (59.1)
 1-3 45 (40.9)
Chemotherapy
 5-FU/MMC 94 (85.5)
 Other 15 (13.6)
 None 1

5FU, 5-fluorouracil; MMC, mitomycin C.